Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dreyer

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Acta Oto-Laryngologica|August 8, 2013
Contrast-agent enhancement in ex vivo flat-panel computed tomography of locally advanced laryngeal cancerTobias Kroll, Shachi Jenny Sharma, Thomas Dreyer, et al.
European Urology|April 25, 2025
Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 TrialThomas Dreyer, Simone Brandt, Knud Fabrin, et al.
Scandinavian Journal of Urology|January 28, 2021
Which data are available in central registries on bladder cancer patients in the five Nordic countriesStefanie Korsgaard Körner, Thomas Dreyer, Erik Skaaheim Haug, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 6, 2002
Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary arteryBei Huang, Thomas Dreyer, Martin Heidt, et al.
Cancer Research|September 26, 2014
A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cellsKristin Kunze, Tilmann Spieker, Ulrike Gamerdinger, et al.
Cancers|May 16, 2023
Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION TrialNessn Azawi, Juan Luis Vásquez, Thomas Dreyer, et al.
European Journal of Pediatrics|June 3, 2004
Management of stage I cervical sarcoma botryoides in childhood and adolescenceSusanne E M Gruessner, Charles O A Omwandho, Thomas Dreyer, et al.
International Journal of Molecular Sciences|August 7, 2021
Differential Expression of Peroxisomal Proteins in Distinct Types of Parotid Gland TumorsMalin Tordis Meyer, Christoph Watermann, Thomas Dreyer, et al.
Laryngo- Rhino- Otologie|March 3, 2020
[Mucoepidermoidcarcinoma - Importance in molecular pathology]Lisa Nachtsheim, Christoph Arolt, Thomas Dreyer, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2020
Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomasChristoph Arolt, Moritz Meyer, Vanessa Ruesseler, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Acta Oto-Laryngologica|August 8, 2013
Contrast-agent enhancement in ex vivo flat-panel computed tomography of locally advanced laryngeal cancerTobias Kroll, Shachi Jenny Sharma, Thomas Dreyer, et al.
European Urology|April 25, 2025
Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 TrialThomas Dreyer, Simone Brandt, Knud Fabrin, et al.
Scandinavian Journal of Urology|January 28, 2021
Which data are available in central registries on bladder cancer patients in the five Nordic countriesStefanie Korsgaard Körner, Thomas Dreyer, Erik Skaaheim Haug, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 6, 2002
Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary arteryBei Huang, Thomas Dreyer, Martin Heidt, et al.
Cancer Research|September 26, 2014
A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cellsKristin Kunze, Tilmann Spieker, Ulrike Gamerdinger, et al.
Cancers|May 16, 2023
Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION TrialNessn Azawi, Juan Luis Vásquez, Thomas Dreyer, et al.
European Journal of Pediatrics|June 3, 2004
Management of stage I cervical sarcoma botryoides in childhood and adolescenceSusanne E M Gruessner, Charles O A Omwandho, Thomas Dreyer, et al.
International Journal of Molecular Sciences|August 7, 2021
Differential Expression of Peroxisomal Proteins in Distinct Types of Parotid Gland TumorsMalin Tordis Meyer, Christoph Watermann, Thomas Dreyer, et al.
Laryngo- Rhino- Otologie|March 3, 2020
[Mucoepidermoidcarcinoma - Importance in molecular pathology]Lisa Nachtsheim, Christoph Arolt, Thomas Dreyer, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2020
Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomasChristoph Arolt, Moritz Meyer, Vanessa Ruesseler, et al.
Pageof 4